First Time Loading...

FibroGen Inc
NASDAQ:FGEN

Watchlist Manager
FibroGen Inc Logo
FibroGen Inc
NASDAQ:FGEN
Watchlist
Price: 1.15 USD -1.71% Market Closed
Updated: Apr 20, 2024
Section:
 

Wall Street
Price Targets

FGEN Price Targets Summary
FibroGen Inc

Wall Street analysts forecast FGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FGEN is 1.79 USD with a low forecast of 1.52 USD and a high forecast of 2.1 USD.

FGEN Lowest Forecast
Wall Street Target
1.52 USD
32% Upside
FGEN Average Forecast
Wall Street Target
1.79 USD
55% Upside
FGEN Highest Forecast
Wall Street Target
2.1 USD
83% Upside
Lowest
Price Target
1.52 USD
32% Upside
Average
Price Target
1.79 USD
55% Upside
Highest
Price Target
2.1 USD
83% Upside
FibroGen Inc Competitors:
Price Targets
I
086890
Isu Abxis Co Ltd
130% Upside
ARMP
Armata Pharmaceuticals Inc
206% Upside
GNS
Genus PLC
69% Upside
ALGEN
Genoway SA
71% Upside
I
086890
Isu Abxis Co Ltd
130% Upside
ARMP
Armata Pharmaceuticals Inc
206% Upside
GNS
Genus PLC
69% Upside
ALGEN
Genoway SA
71% Upside
BIOPOR
Bioporto A/S
305% Upside
HRTX
Heron Therapeutics Inc
170% Upside
RXRX
Recursion Pharmaceuticals Inc
80% Upside
VITR
Vitrolife AB
50% Upside

Revenue
Forecast

Revenue Estimate
FibroGen Inc

For the last 8 years the compound annual growth rate for FibroGen Inc's revenue is -2%. The projected CAGR for the next 3 years is 12%.

-2%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
FibroGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
FibroGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
What are analyst estimates?

See Also

Summary
FGEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
FGEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FGEN stock valuation using valuation multiples.
Wall Street Estimates
FGEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FGEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FGEN's stock price target?
Price Target
1.79 USD

According to Wall Street analysts, the average 1-year price target for FGEN is 1.79 USD with a low forecast of 1.52 USD and a high forecast of 2.1 USD.

What is FibroGen Inc's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for FibroGen Inc's revenue is -2%. The projected CAGR for the next 3 years is 12%.

ALPHA SPREAD
Join more than 129,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.